Atezolizumab/hyaluronidase
id:
atezolizumab-hyaluronidase-222-478494
title:
Atezolizumab/hyaluronidase
text:
Atezolizumab/hyaluronidase, sold under the brand name Tecentriq Hybreza, is a Fixed dose combination medication used for the treatment of non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma. It contains atezolizumab, a programmed death-ligand 1 (PD-L1) blocking monoclonal antibody; and hyaluronidase, an endoglycosidase. It is taken by subcutaneous injection. The most common adverse reactions include fatigue, musculoskeletal pain,
brand slug:
wiki
category slug:
encyclopedia
description:
Combination medication
original url:
https://en.wikipedia.org/wiki/Atezolizumab/hyaluronidase
date created:
2024-09-14T05:29:46Z
date modified:
2024-09-14T05:29:46Z
main entity:
image:
fields total:
13
integrity:
14